A detailed history of Alphabet Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Alphabet Inc. holds 1,036,937 shares of DXCM stock, worth $79.1 Million. This represents 4.76% of its overall portfolio holdings.

Number of Shares
1,036,937
Previous 1,036,937 -0.0%
Holding current value
$79.1 Million
Previous $118 Million 40.89%
% of portfolio
4.76%
Previous 7.4%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$110.31 - $140.45 $83.2 Million - $106 Million
-753,836 Reduced 42.1%
1,036,937 $118 Million
Q1 2024

May 02, 2024

SELL
$114.22 - $140.1 $216 Million - $265 Million
-1,891,112 Reduced 51.36%
1,790,773 $248 Million
Q4 2023

Feb 08, 2024

BUY
$75.49 - $124.16 $229 Million - $376 Million
3,027,031 Added 462.25%
3,681,885 $457 Million
Q3 2023

Nov 09, 2023

SELL
$86.06 - $137.93 $48 Million - $77 Million
-557,952 Reduced 46.01%
654,854 $61.1 Million
Q2 2023

Aug 03, 2023

SELL
$112.47 - $130.98 $4.18 Million - $4.87 Million
-37,194 Reduced 2.98%
1,212,806 $156 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $63.7 Million - $92 Million
-750,000 Reduced 37.5%
1,250,000 $142 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $167 Million - $206 Million
-2,188,154 Reduced 52.25%
2,000,000 $161 Million
Q2 2022

Nov 14, 2022

BUY
$67.99 - $132.89 $213 Million - $417 Million
3,137,559 Added 298.65%
4,188,154 $312 Million
Q1 2022

Nov 14, 2022

BUY
$94.08 - $130.2 $32.6 Million - $45.1 Million
346,584 Added 49.23%
1,050,595 $537 Million
Q4 2021

Nov 14, 2022

SELL
$129.87 - $162.82 $13.2 Million - $16.6 Million
-101,670 Reduced 12.62%
704,011 $378 Million
Q4 2019

Nov 14, 2022

BUY
$36.62 - $57.29 $25.5 Million - $39.8 Million
695,224 Added 629.41%
805,681 $176 Million
Q4 2018

Nov 14, 2022

BUY
$26.99 - $37.37 $2.98 Million - $4.13 Million
110,457 New
110,457 $3.27 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.